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Abstract
The	dengue	virus	is	now	the	most	widespread	arbovirus	affecting	human	populations,	
causing	significant	economic	and	social	impact	in	South	America	and	South-	East	Asia.	
Increasing	urbanization	and	globalization,	coupled	with	insufficient	resources	for	con-
trol,	misguided	policies	or	lack	of	political	will,	and	expansion	of	its	mosquito	vectors	
are	some	of	the	reasons	why	interventions	have	so	far	failed	to	curb	this	major	public	
health	problem.	Computational	approaches	have	elucidated	on	dengue’s	population	
dynamics	with	the	aim	to	provide	not	only	a	better	understanding	of	the	evolution	and	
epidemiology	of	the	virus	but	also	robust	intervention	strategies.	It	is	clear,	however,	
that	these	have	been	insufficient	to	address	key	aspects	of	dengue’s	biology,	many	of	
which	will	play	a	crucial	role	for	the	success	of	future	control	programmes,	including	
vaccination.	Within	a	multiscale	perspective	on	this	biological	system,	with	the	aim	of	
linking	evolutionary,	ecological	and	epidemiological	thinking,	as	well	as	to	expand	on	
classic	modelling	assumptions,	we	here	propose,	discuss	and	exemplify	a	few	major	
computational	 avenues—real-	time	 computational	 analysis	 of	 genetic	 data,	 phylody-
namic	modelling	 frameworks,	 within-	host	model	 frameworks	 and	 GPU-	accelerated	
computing.	We	argue	that	these	emerging	approaches	should	offer	valuable	research	
opportunities	over	the	coming	years,	as	previously	applied	and	demonstrated	in	the	
context	of	other	pathogens.
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1  | BACKGROUND
1.1 | The dengue virus
Dengue	virus	 (DENV)	 is	a	single-	stranded,	positive-	sense	RNA	virus	
with	a	population	comprised	of	four	antigenically	distinct	groups,	or	
serotypes	 (DENV1–4),	that	present	similar	population	dynamics	and	
are	the	cause	of	clinically	indistinguishable	illnesses	in	humans	(Gubler,	
1998;	Halstead,	2007;	Kyle	&	Harris,	2008).	Classification	based	on	
genomic	organization,	homology	and	antigenic	cross-	reactivity	place	
DENV	into	the	Flavivirus	genus	of	the	viral	family	Flaviviridae	(Calisher,	
Karabatsos,	 Dalrymple,	 Shope,	 &	 Porterfield,	 1989).	 More	 than	 70	
flaviviruses	 have	 so	 far	 been	 identified	 (Kuno,	 Chang,	 Tsuchiya,	
Karabatsos,	 &	 Cropp,	 1998),	 many	 of	 which	 are	 important	 human	
pathogens,	including	the	hepatitis	C	virus	(HCV),	Japanese	encephali-
tis	virus	(JEV),	West	Nile	virus	(WNV),	yellow	fever	virus	(YFV)	and	the	
recently	emerged	Zika	virus	(ZIKV).	Among	the	ones	that	are	vector-	
born	 (all	 except	HCV),	 DENV	 is	 responsible	 for	 the	 highest	 human	
morbidity	and	mortality,	with	children	carrying	the	highest	burden	of	
disease	(Anders	et	al.,	2011;	Jain	&	Chaturvedi,	2010;	Murray,	Quam,	
&	Wilder-	Smith,	2013).
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1.2 | Dengue evolution
Observations	were	made	in	the	late	1970s	of	dengue-	like	viruses	and	
respective	animal	 reservoirs	 in	Asia	and	West	Africa	 (Aiken	&	Leigh,	
1978).	 Since	 then,	 a	wide	 number	 of	 sylvatic	 strains	 (i.e.,	 of	 animal	
origin)	have	been	isolated	and	reported	to	belong	to	each	of	the	line-
ages	of	human-	bearing	serotypes,	proposing	a	zoonotic	origin	for	the	
pathogen	(Holmes	&	Twiddy,	2003).	Introduction	of	each	serotype	into	
the	human	population	was	extrapolated	to	have	taken	place	at	differ-
ent	time	points,	with	DENV2’s	most	recent	common	ancestor	being	
the	 oldest,	 estimated	 to	 be	 approximately	 1,000	years	 old	 (Twiddy,	
Holmes,	&	Rambaut,	2003;	Weaver	&	Vasilakis,	2009),	roughly	corre-
sponding	to	some	of	the	first	reports	of	dengue-	like	illnesses	(Vasilakis	
&	Weaver,	 2008;	Tang	 et	al.,	 2010;	Weaver	 &	Vasilakis,	 2009).	The	
genetic	distance	between	currently	circulating	serotypes	is	likely	a	by-	
product	 of	 allopatric	 evolution	 due	 to	 ecological	 partitioning	 of	 an-
cestral	sylvatic	strains	 (Holmes	&	Twiddy,	2003;	Weaver	&	Vasilakis,	
2009).	This	hypothesis	is	sustained	not	only	by	DENV’s	current	popu-
lation	structure,	but	also	by	studies	that	report	sylvatic	and	endemic	
(i.e.,	human	bearing)	strains	 to	exhibit	similar	evolutionary	 rates	and	
(cell-	)	infection	potential	(Twiddy	et	al.,	2002;	Vasilakis	et	al.,	2007).
Within	each	serotype,	nucleic	acid	sequencing	techniques	have	
identified	 genetic	 subgroups	or	 lineages,	 commonly	denominated	
as	dengue	genotypes	(Tang	et	al.,	2010;	Weaver	&	Vasilakis,	2009).	
Notably,	 the	 overall	 amino	 acid	 sequence	 similarity	 among	 geno-
types	 is	generally	above	90%	(Holmes	&	Twiddy,	2003;	Leitmeyer	
et	al.,	 1999),	 whereas	 between	 serotypes,	 it	 can	 range	 between	
60%	 and	 80%	 (Irie,	 Mohan,	 Sasaguri,	 Putnak,	 &	 Padmanabhan,	
1989;	 Rothman,	 2011).	 Although	 RNA	 viruses	 generally	 pres-
ent	 rapid	 evolution	 and	 accumulation	 of	 diversity	 occurring	 at	 a	
similar	 time-	scale	 as	 their	 host’s	 ecological	 dynamics	 (Grenfell,	
Pybus,	Gog,	Wood,	&	Daly,	2004),	studies	have	demonstrated	that	
strong	 purifying	 selection	 dominates	 DENV’s	 recent	 evolution	
(Bennett,	Holmes,	Chirivella,	Rodriguez,	&	Beltran,	2003;	Holmes,	
2003;	Holmes	&	Twiddy,	2003;	Weaver	&	Vasilakis,	2009;	Zhang,	
Mammen,	 Chinnawirotpisan,	 Klungthong,	 &	 Rodpradit,	 2005).	 A	
prevailing	hypothesis	 is	that	the	virus	has	evolved	to	replicate	ef-
ficiently	 in	 both	 the	 vertebrate	 and	 arthropod	 hosts	 (Filomatori,	
Carballeda,	Villordo,	Aguirre,	&	Pallarés,	2017),	expressing	a	com-
promise	genome	 in	which	most	amino	acid	changes	are	expected	
to	 be	 deleterious	 and	 selectively	 removed	 from	 the	 population	
(Holmes,	 2003;	 Holmes	 &	 Twiddy,	 2003;	 Weaver	 &	 Vasilakis,	
2009).	 The	 lack	 of	 recombination,	 supported	 by	 rare	 reports	 on	
naturally	 occurring	 recombinants	 (Waman,	 Kolekar,	 Ramtirthkar,	
Kale,	&	Kulkarni-	Kale,	2016;	Weaver	&	Vasilakis,	2009),	 is	further	
believed	 to	 limit	 the	 fixation	 and	 emergence	 of	 single,	 positively	
selected	mutations	due	to	clonal	interference	(Grenfell	et	al.,	2004;	
Lourenço	&	Recker,	2010;	Miralles,	Gerrish,	Moya,	&	Elena,	1999).
1.3 | Dengue transmission cycle
Dengue	virus	is	transmitted	to	humans	by	the	bite	of	infectious	mosqui-
toes.	Two	mosquito	species	have	been	identified	as	the	main	disease	
vectors:	Aedes aegypti and Ae. albopictus.	 Intercontinental	changes	 in	
the	second	half	of	the	20th	century,	in	particular	the	post-	World	War	
II	boom	in	urbanization	and	globalization,	have	facilitated	the	introduc-
tion	 and	 establishment	 of	 dengue’s	 two	 principal	 mosquito	 vectors	
into	 many	 major	 urban	 and	 peri-	urban	 settings	 and	 resulted	 in	 the	
worldwide	establishment	of	endemic	transmission	cycles	(i.e.,	between	
humans;	 Vasilakis,	 &	Weaver,	 2008;	Murray	 et	al.,	 2013;	Weaver	&	
Vasilakis,	2009).	Ae. aegypti	is	particularly	domesticated	and	often	uses	
artificial	water	containers	found	within	and	around	human	habitats	as	
breeding	sites.	Adult	mosquitoes	are	optional	haematophages,	but	fe-
males	require	blood	for	egg	production	and	show	strong	preference	for	
human	blood	meals	(Scott,	Morrison,	Lorenz,	Clark,	&	Strickman,	2000).
In	contrast,	 the	transmission	cycle	of	sylvatic	viruses	takes	place	
in	forest	environments	of	South-	East	Asia	and	West	Africa	between	
nonhuman	 primates	 and	 arboreal	 Aedes	 species.	 Rural	 populations	
living	 in	 close	proximity	 to	 forested	or	 plantation	 areas	 are	periodi-
cally	exposed	to	such	variants	 (Holmes	&	Twiddy,	2003;	Vasilakis,	&	
Weaver,	2008;	Weaver	&	Vasilakis,	2009).	Secondary	transmission	is	
rarely	reported,	which	may	be	a	combined	result	of	limited	human-	to-	
vector	transmission	potential,	underreporting	due	to	low	pathogenic-
ity,	weak	surveillance	and	lack	of	peridomestic	vectors	(Ae. aegypti and 
Ae. albopictus).
1.4 | Dengue epidemiology
The	epidemiological	 picture	 of	 dengue	 across	 the	world	 is	 variable.	
While	hyperendemicity	is	classically	associated	with	South-	East	Asia,	
the	 21st	 century	 has	 witnessed	 the	 endemic	 establishment	 of	 the	
virus	 in	 South	 and	 Central	 America	 (Brathwaite	 Dick,	 San	 Martín,	
Montoya,	 del	 Diego,	 &	 Zambrano,	 2012;	 San	 Martín,	 Brathwaite,	
Zambrano,	Solórzano,	&	Bouckenooghe,	2010).	Dengue	has	also	re-
cently	emerged	 in	 the	United	States,	with	 repeated	but	 so	 far	 self-	
contained	outbreaks	in	Florida	and	Texas	(Guzman,	Halstead,	Artsob,	
Buchy,	&	Farrar,	2010;	Radke,	Gregory,	Kintziger,	 Sauber-	Schatz,	&	
Hunsperger,	 2012;	 Thomas,	 Santiago,	 Abeyta,	 Hinojosa,	 &	 Torres-	
Velasquez,	2016).	 In	Europe,	outbreaks	 in	 Italy,	France,	Greece	and	
the	Madeira	island	(Portugal)	have	been	reported	in	recent	years,	but	
with	no	observations	of	endemic	circulation	(Cavrini,	Gaibani,	Pierro,	
Rossini,	&	Landini,	2009;	Gautret,	Botelho-	Nevers,	Charrel,	&	Parola,	
2010;	Gjenero-	Margan,	 Aleraj,	 Krajcar,	 Lesnikar,	 &	 Klobučar,	 2011;	
Lourenço	&	Recker,	2014).
Poor	 surveillance,	 no	 official	 reporting	 to	 the	WHO	 (Jaenisch,	
Junghanss,	Wills,	Brady,	&	Eckerle,	2014)	and	the	high	prevalence	
of	 other	 diseases	 makes	 the	 situation	 in	 Africa	 more	 uncertain.	
Recently,	outbreaks	of	dengue	or	dengue-	like	illness	were	reported	
in	dry	countries	of	Eastern	Africa	and	South	West	Asia,	such	as	Saudi	
Arabia	(Aziz,	Al-	Shami,	Mahyoub,	Hatabbi,	&	Ahmad,	2014),	Yemen	
(Bin	 Ghouth,	 Amarasinghe,	 &	 Letson,	 2012),	 Sudan	 (Seidahmed,	
Hassan,	Soghaier,	Siam,	&	Ahmed,	2012)	and	Madagascar	(Schwarz,	
Girmann,	 Randriamampionona,	 Bialonski,	 &	Maus,	 2012).	 In	 2004	
and	2009,	epidemics	occurred	 in	the	 isolated	populations	of	Cape	
Verde	 (Franco,	 Di	 Caro,	 Carletti,	 Vapalahti,	 &	 Renaudat,	 2010),	
Mauritius	 islands	 (Issack,	 2010)	 and	 Reunion	 island	 (Larrieu,	
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Dehecq,	 Balleydier,	 Jaffar,	 &	 Michault,	 2012),	 and	 a	 major	 epi-
demic	in	Pakistan	took	place	in	2013	(Kraemer,	Perkins,	Cummings,	
Zakar,	&	Hay,	2015;	Khan,	Khan,	&	Amin,	2016).	Together	with	the	
widespread	 presence	 of	Ae. aegypti and Ae. albopictus,	 this	would	
indicate	 that	 the	 burden	of	 dengue	 in	Africa	 is	 likely	 to	 be	worse	
than	previously	acknowledged	(Guzman	et	al.,	2010;	Jaenisch	et	al.,	
2014;	Kyle	&	Harris,	2008).
Driven	by	seasonal	variation	in	vector	abundances,	incidence	pat-
terns	are	usually	characterized	by	annual	outbreaks	(Figure	1a;	Cuong,	
Hien,	Duong,	Phong,	&	Cam,	2011;	Lourenço	&	Recker,	2013;	Nisalak,	
Endy,	Nimmannitya,	Kalayanarooj,	&	Thisayakorn,	2003).	In	addition,	
multi-	annual	epidemics	with	a	2-	to	5-	year	period	have	also	been	re-
ported	 in	highly	endemic	settings	 (Figure	1a,b;	Bennett,	Drummond,	
Kapan,	Suchard,	&	Muñoz-	Jordán,	2010;	Cummings,	 Irizarry,	Huang,	
Endy,	&	Nisalak,	2004;	Cuong	et	al.,	2011;	Lourenço	&	Recker,	2013;	
Nisalak	et	al.,	2003;	Thai,	Cazelles,	Nguyen,	Vo,	&	Boni,	2010).	In	con-
trast,	 regions	where	transmission	has	been	historically	 low	or	where	
dengue	 serotypes	were	 only	 recently	 introduced	 are	more	 likely	 to	
show	wave-	like,	increasing	patterns	of	incidence	(Figure	1c,f).	Spatial	
heterogeneities	 are	also	 common	 in	 reported	data,	highlighting	 that	
the	 success	 of	 dengue	viruses	 can	 be	 dictated	by	 numerous	 demo-
graphic	and	ecological	determinants	(Figure	1f;	Adams	&	Kapan,	2009;	
Beebe,	 Cooper,	 Mottram,	 &	 Sweeney,	 2009;	 Campbell,	 Haldeman,	
Lehnig,	 Munayco,	 &	 Halsey,	 2015;	 Chew,	 Woon,	 Amin,	 Adnan,	 &	
Abdul	Wahab,	2016;	Cummings	et	al.,	2004;	Lourenço	&	Recker,	2010;	
Lourenço	&	Recker,	2013).
Where	all	 four	serotypes	cocirculate	endemically,	 relative	preva-
lence	levels	of	each	serotype	are	characterized	by	oscillatory	behaviour	
with	 periods	 of	 8–10	years	 (Figure	1d,e;	 Adams,	 Holmes,	 Zhang,	
Mammen,	 &	Nimmannitya,	 2006;	 Bennett	 et	al.,	 2010;	 Lourenço	 &	
Recker,	2013;	Nisalak	et	al.,	2003).	Whereas	 incidence	dynamics	are	
thought	 to	 be	 driven	 by	 a	 complex	 interplay	 of	 local	 factors,	 from	
the	abundance	of	susceptible	humans,	climate	and	viral	traits,	to	the	
density	 and	 distribution	 of	 both	 the	 human	 and	 the	vector	 popula-
tions	(Johansson,	Dominici,	&	Glass,	2009;	Morrison,	Minnick,	Rocha,	
Forshey,	&	Stoddard,	2010;	Nagao,	Svasti,	Tawatsin,	&	Thavara,	2008;	
Tsuzuki,	Vu,	Higa,	Nguyen,	&	Takagi,	2009;	Williams,	Bader,	Kearney,	
Ritchie,	&	Russell,	2010),	there	is	lack	of	evidence	that	these	factors	
directly	 influence	 the	 qualitative	 properties	 of	 serotype	 cyclical	 be-
haviour,	which	seems	to	be	a	universal	feature	of	dengue	epidemiology.
1.5 | Human infections, immunity and disease
Primary	infections	in	humans	with	any	of	the	four	serotypes	are	gen-
erally	mild	with	 the	majority	 of	 cases	 believed	 to	 be	 asymptomatic	
(Kyle	&	Harris,	2008;	Nisalak	et	al.,	2003).	Infections	usually	result	in	
a	short-	lived,	febrile	illness,	which	is	commonly	referred	to	as	dengue 
fever	(DF)	and	is	characterized	by	arthralgia	(joint	pain),	myalgia	(mus-
cle	 pain),	 low-	grade	 fever	 and	 retro-	orbital	 headaches	 (Balmaseda,	
Hammond,	Tellez,	Imhoff,	&	Rodriguez,	2006;	Burke,	Nisalak,	Johnson,	
&	Scott,	1988;	Wichmann,	Yoon,	Vong,	Limkittikul,	&	Gibbons,	2011).	
In	some	cases,	this	may	progress	to	more	severe	and	life-	threatening	
forms	 of	 disease—dengue haemorrhagic fever	 (DHF)	 or	dengue shock 
syndrome	 (DSS)—with	manifestations	 of	 circulatory	 failure,	 vascular	
permeability	 and	 haemorrhagic	 symptoms	 (Gubler,	 1998;	 Halstead,	
2007).
F IGURE  1 Epidemiological	time	series	of	reported	dengue	cases	for	three	different	countries.	(a)	Total	monthly	incidence	for	Puerto	Rico.	
(b)	Annual	dengue	haemorrhagic	fever	incidence	per	100,000	individuals	in	Thailand.	(c)	Total	annual	incidence	for	Brazil.	(d)	Monthly	serotype,	
relative	prevalence	for	Puerto	Rico.	(e)	Yearly	serotype,	relative	prevalence	for	Thailand.	(f)	Yearly	absolute	incidence	for	the	north	and	south	of	
Brazil	(see	Appendix: Data Description	for	details)
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Flaviviruses	 are	 known	 to	 induce	 the	 phenomenon	 of	 original 
antigenic sin	 (OAS)	 (Francis,	 1960),	 in	 which	 B-	cell	 clones	 sequen-
tially	 challenged	 by	 viruses	 of	 the	 same	 family	 initially	 respond	 by	
synthesizing	 antibodies	 with	 higher	 affinity	 to	 a	 previous	 infecting	
virus	 (Halstead,	 Rojanasuphot,	 &	 Sangkawibha,	 1983).	 This	 creates	
a	cascade	of	regulatory	changes	that	facilitates	expression	and	syn-
thesis	of	pro-	inflammatory	cytokines	and	induces	a	positive	feedback	
that	 increases	 the	 rate	 of	 intracellular	 infection,	 leading	 to	 higher	
viraemia	 levels	 and	worse	 clinical	 outcomes	 (Beltramello,	Williams,	
Simmons,	 Macagno,	 &	 Simonelli,	 2010;	 Fernandez-	Garcia,	 Mazzon,	
Jacobs,	&	Amara,	2009;	Green,	Vaughn,	Kalayanarooj,	Nimmannitya,	
&	Suntayakorn,	1999;	Ubol	&	Halstead,	2010;	Whitehorn	&	Simmons,	
2011).	In	dengue	infections,	this	cascade	is	commonly	referred	to	as	
antibody-dependent enhancement	(ADE)	and	is	mainly	associated	with	
heterologous	DENV	challenges	 (Balsitis,	Williams,	Lachica,	Flores,	&	
Kyle,	2010;	Halstead,	Mahalingam,	Marovich,	Ubol,	&	Mosser,	2010;	
Wrammert,	Onlamoon,	Akondy,	Perng,	&	Polsrila,	2012)	or	the	pres-
ence	of	maternal	antibodies	in	infants	(Chau,	Hieu,	Anders,	Wolbers,	
&	Lien,	2009).
Generally,	 cellular	 immune	 responses	 (T	 cell)	 to	DENV	 are	 seen	
to	 cover	 most	 of	 the	 viral	 proteins	 (Duangchinda,	 Dejnirattisai,	
Vasanawathana,	 Limpitikul,	 &	 Tangthawornchaikul,	 2010;	 Rothman,	
2011),	 but	with	 a	 particular	 dominant	 signal	 for	NS3	 (Duangchinda	
et	al.,	 2010),	 which	 represents	 only	 ≈20%	 of	 DENV	 amino	 acid	
coding	 sequence	 (Rothman,	 2011).	 T-	cell	 clones	 can	 be	 serotype	
cross-	reactive,	 sero-	specific	or	even	 strain-	specific	 (i.e.,	within	 sero-
type;	 Bashyam,	 Green,	 &	 Rothman,	 2006;	Mangada,	 Endy,	 Nisalak,	
Chunsuttiwat,	&	Vaughn,	2002;	Rothman,	2011;	Sierra,	García,	Pérez,	
Morier,	 &	 Rodríguez,	 2002;	 Ubol	 &	 Halstead,	 2010).	 The	 cross-	
reactivity	 is	 not	 surprising,	 however,	 given	 the	 ≈70% amino acid 
identity	between	DENV1	and	DENV4	(Rothman,	2011).	OAS	in	T-	cell	
responses,	 including	 inflammation	 and	 cytokine-	induced	 alteration	
of	vascular	permeability	 (Rothman,	2011),	have	also	been	described	
in	 secondary	 infections	 (Mongkolsapaya,	 Dejnirattisai,	 Xiao-	ning,	
Vasanawathana,	&	Tangthawornchaikul,	2003),	with	consequences	for	
pathogenicity	(Bashyam	et	al.,	2006;	Duangchinda	et	al.,	2010;	Imrie,	
Meeks,	Gurary,	Sukhbataar,	&	Kitsutani,	2007;	Mangada	et	al.,	2002;	
Stephens,	Klaythong,	Sirikong,	Vaughn,	&	Green,	2002).
Hence,	available	evidence	from	both	humoral	and	cellular	 immu-
nity	 suggests	 that	 the	 clinical	 outcome	 of	 DENV	 infection	 is	 finely	
tuned	to	an	individual’s	immune	response,	in	particular	to	the	degree	
of	OAS	and	associated	inflammatory	levels.	Factors	that	may	influence	
the	regulation	of	an	individual’s	response,	in	particular	for	secondary	
challenges,	 might	 include	 the	 following:	 host	 genetics,	 viral	 strain,	
sequence	of	 infecting	serotypes,	age,	co-	infection	with	other	patho-
gens,	etc.	However,	there	is	a	major	gap	in	our	current	knowledge	on	
reliable,	immunological	markers	for	clinical	outcomes,	and	discerning	
between	 such	 factors	 is	 often	 difficult	 (Rothman,	 2011),	 although,	
generally,	 the	most	 significant	 risk	 factor	 for	 severe	 disease	 is	 sec-
ondary	infection	with	an	heterologous	serotype	as	a	primer	for	OAS	
(Burke	et	al.,	1988;	Guzman	&	Kouri,	2008;	Halstead	et	al.,	2010;	Kyle	
&	Harris,	2008;	Sangkawibha,	Rojanasuphot,	Ahandrik,	Viriyapongse,	
&	Jatanasen,	1984;	Thein,	Aung,	Shwe,	Aye,	&	Zaw,	1997;	Rothman	&	
Ennis,	1999;	Halstead	&	O’Rourke,	1977;	Dejnirattisai,	Jumnainsong,	
Onsirisakul,	Fitton,	&	Vasanawathana,	2010).
Recovery	is	thought	to	result	 in	 lifelong	protection	against	the	in-
fecting	 serotype	 (homologous	 immunity)	 (but	 see	 (Forshey,	 Reiner,	
Olkowski,	Morrison,	&	Espinoza,	2016;	Waggoner,	Balmaseda,	Gresh,	
Sahoo,	&	Montoya,	2016)	for	possible	incomplete	protection).	A	period	
of	 6–36	months	 of	 temporary	 cross-	protective	 immunity	 to	 all	 sero-
types	 has	 also	 been	 suggested	 after	 recovery	 (see	 e.g.,	 Sabin,	 1952;	
Reich,	Shrestha,	King,	Rohani,	&	Lessler,	2013),	although	 it	 is	still	un-
certain	whether	 this	 form	of	 immunity	 solely	protects	 against	 clinical	
disease	 or	 completely	 prevents	 infection	 (Bhoomiboonchoo,	 Nisalak,	
Chansatiporn,	 Yoon,	 &	 Kalayanarooj,	 2015;	 Anderson	 et	al.,	 2014;	
Kochel,	 Watts,	 Halstead,	 Hayes,	 &	 Espinoza,	 2002;	 Kochel,	 Watts,	
Gozalo,	Ewing,	&	Porter,	2005;	Olkowski,	Forshey,	Morrison,	Rocha,	&	
Vilcarromero,	2013).	Upon	recovery	from	a	secondary,	heterologous	in-
fection,	humans	are	believed	to	be	(clinically)	protected	against	further	
challenges.	Due	to	the	rarity	of	third	and	fourth	infections	in	clinical	data	
and	the	difficulties	in	assessing	an	individual’s	infection	history	because	
of	high	antibody	cross-	reactivity	in	serological	assays	(Halstead,	2007;	
Nisalak	et	al.,	2003;	Olkowski	et	al.,	2013;	Gibbons,	Kalanarooj,	Jarman,	
Nisalak,	&	Vaughn,	2007),	it	is	not	yet	clear	to	what	degree	secondary	in-
fection	prevents	re-	infections	or	simply	renders	subsequent	infections,	
even	by	previously	un-	experienced	serotypes,	clinically	silent.
1.6 | Immune interactions and computational  
approaches
Mathematical	and	computational	models	are	recognized	as	an	impor-
tant	tool	in	infectious	disease	epidemiology	and	have	been	applied	to	
dengue	since	the	mid-	20th	century.	Hand-	in-	hand	with	the	increase	
in	the	global	distribution	and	burden	of	dengue,	the	number	of	model-
ling	studies	has	also	gone	up	 (Figure	2).	Topics	have	 ranged	widely,	
from	estimations	of	dengue’s	reproductive	number	to	the	 impact	of	
climate	and	space	on	disease	transmission	and	spread,	to	the	evalua-
tion	and	assessment	of	disease	control	strategies.	Dengue’s	complex	
epidemiological	dynamics,	with	multi-	annual	outbreaks	and	sequential	
replacement	of	dominant	serotypes,	has	also	attracted	a	fair	share	of	
the	 attention	 of	 the	modelling	 community,	with	many	 studies	 con-
centrating	on	immune	interactions	between	dengue	serotypes,	either	
through	ADE	and/or	by	means	of	cross-	immunity.	In	fact,	the	incorpo-
ration	of	immune	interaction	has	become	ubiquitous	to	most	dengue	
models	and	hence	deserves	a	little	more	detail	here.
It	 is	broadly	recognized	that	 immune	competition	can	act	 to	de-
synchronize	antigenically	diverse	pathogens,	such	as	dengue,	malaria	
(Plasmodium falciparum)	or	the	influenza	A	virus,	and	cause	nonlinear	
or	 chaotic	 oscillations	 not	 too	 dissimilar	 to	 the	 observed	 epidemio-
logical	 patterns	 of	 dengue.	 For	 dengue,	 competition	 between	 sero-
types	 can	 be	 driven	 by	ADE	 of	 secondary,	 heterologous	 infections	
or	 through	 (temporary	or	permanent)	cross-	immunity.	Both	types	of	
interactions	are	assumed	to	affect	the	transmissibility	of	subsequent	
infections,	 leading	 to	 frequency-	dependent	 selection	 that	 has	 been	
demonstrated	to	generate	oscillatory	behaviour	and	further	facilitate	
serotype	persistence	(Schwartz,	Shaw,	Cummings,	Billings,	&	McCrary,	
     |  5LOURENÇO Et aL.
2005;	 Ferguson,	 Anderson,	 &	 Gupta,	 1999;	 Cummings,	 Schwartz,	
Billings,	 Shaw,	 &	 Burke,	 2005;	 Aguiar,	 Kooi,	 &	 Stollenwerk,	 2008;	
Wearing	&	Rohani,	2006;	Adams	&	Boots,	2006;	Hu,	Thoens,	Bianco,	
Edlund,	&	Davis,	2013).
With	 regard	 to	ADE,	 initial	 criticism	 concerning	 the	 level	 of	 en-
hancement	 required	 for	 serotype	 desynchronization	 could	 be	 coun-
tered	by	also	assuming	enhancement	in	the	susceptibility	to	secondary	
infections	 (see	e.g.,	 (Recker,	Blyuss,	 Simmons,	Hien,	&	Wills,	2009)).	
Importantly,	 however,	 empirical	 evidence	 supporting	 a	 universal	 in-
crease	 in	 the	 transmission	 potential	 of	 secondary	 infections	 is	 still	
lacking.	That	is,	while	the	ADE	phenomenon	has	been	shown	both	in	
in	vitro	and	 in	vivo	studies	 (Halstead	et	al.,	2010;	Dejnirattisai	et	al.,	
2010;	Halstead,	2011),	 its	actual	onsequences	 for	disease	 transmis-
sion	and	the	proportion	of	hosts	contributing	to	ADE-	induced	pheno-
types	at	any	given	time	are	largely	unknown.
Cross-	immunity,	where	an	infection	by	one	serotype	negatively	
affects	the	fitness	of	subsequently	infecting	serotypes,	has	equally	
been	put	forward	in	modelling	studies	to	explain	dengue’s	complex	
epidemiology	 (Adams	et	al.,	2006;	Reich	et	al.,	2013;	Aguiar	et	al.,	
2008;	 Wearing	 &	 Rohani,	 2006).	 Recent	 studies	 on	 prospective	
cohorts	 have	 found	 that	 shorter	 time	 periods	 between	 sequen-
tial	 infections	 are	 associated	with	 some	 degree	 of	 clinical	 protec-
tion	(Anderson	et	al.,	2014;	Montoya,	Gresh,	Mercado,	Williams,	&	
Vargas,	2013).	However,	apart	from	a	single	human	study	conducted	
in	 the	1950s	 (Sabin,	1952),	experimental	support	 for	both	the	na-
ture	 and	duration	of	 cross-	immunity	 is	 still	 lacking.	Consequently,	
there	 is	 no	 broad	 consensus	 about	 the	 protective	 efficacy	 of	 the	
observed	cross-	reactivity	between	dengue	serotypes	and	whether	
cross-	reactive	 responses	 prevent	 infection	 or	 solely	 act	 to	 allevi-
ate	clinical	outcomes.	Model	assumptions	have	therefore	diverged	
significantly	with	regard	to	the	duration	and	the	type	of	protection	
following	a	primary	dengue	infection.
It	 is	worth	noting	 that	 some	of	 the	 controversies	 surrounding	
serotype	 immune	 interactions	 and	 their	 effects	 on	 the	 epidemio-
logical	dynamics	of	dengue	are	partially	consequences	of	the	actual	
modelling	 frameworks	 themselves.	 That	 is,	 deterministic	 models	
based	 on	mass-	action	 principles,	which	 comprise	 the	majority	 of	
mathematical	models	found	in	the	published	 literature,	require	an	
interaction	 term	 in	 order	 to	 desynchronize	 the	 serotypes	 and	 to	
exhibit	 dengue’s	 characteristic	 multi-	annual	 incidence	 patterns.	
Stochastic,	 and	 in	 particular	 individual-	based,	models	 do	 not	 rely	
on	 this	 assumption	 to	 generate	 epidemiological	 time	 series	with	
such	 properties.	 The	 contrasting	 dynamic	 behaviour	 is	 driven	 by	
the	 amplification	 of	 stochastic	 effects	 at	 the	 individual-	level	 (de-
mographic	 stochasticity),	 which	 keeps	 each	 serotype/strain	 in	 a	
transient	 regime	 rather	 than	approaching	 the	expected	determin-
istic	 equilibrium	 even	 in	 the	 absence	 of	 explicit	 desynchronizing	
factors	 (Lourenço	 &	 Recker,	 2013;	 Alonso,	 McKane,	 &	 Pascual,	
2007).	Crucially,	understanding	the	epidemiological	consequences	
of	dengue	immune	interactions	goes	beyond	the	theoretical	argu-
ment	and	has	recently	been	shown	to	be	of	major	 importance	for	
dengue	vaccination	impact	studies	based	on	mathematical	models	
(Lourenço	&	Recker,	2016;	Flasche	et	al.,	2016).
2  | CHALLENGES AND OPPORTUNITIES IN 
COMPUTATIONAL RESEARCH
The	zoonotic	origin,	 separate	endemic	and	sylvatic	 transmission	cy-
cles,	 immunological	 serotype	 interactions	 and	 the	 vast	 diversity	 of	
F IGURE  2 Dengue	publication	over	the	last	five	decades.	Total	number	of	dengue	articles	per	year	(bars)	and	the	percentage	of	those	with	
a	computational	focus	(spikes).	Between	1970	and	2016,	a	total	of	15,267	dengue	articles	were	published,	including	190	modelling	studies	(see	
Appendix	for	details)
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dengue	genotypes	provide	a	valuable	background	for	integrative	evo-
lutionary	approaches	in	the	context	of	dengue.	However,	the	predom-
inant	focus	on	single	biological	scales	(e.g.,	host-	host	transmission)	has	
so	 far	 limited	our	capacity	 to	 link	 important	population	genetic	and	
ecological	 observations	with	 the	pathogen’s	 epidemiological	 behav-
iour	within	a	single	framework.	In	sharp	contrast	to	other	major	viral	
pathogens,	 such	 as	 the	 influenza	A	 virus	 or	 the	 human	 immunode-
ficiency	virus	 (HIV),	evolutionary	 frameworks	do	not	 feature	promi-
nently	in	dengue’s	modelling	literature,	with	the	field	of	phylogenetics	
so	far	dominating	evolutionary	approaches.
In	 general,	 the	 continuing	 geographical	 and	 epidemic	 expansion	
of	dengue’s	genetic	variants	and	mosquito	vectors,	and	the	failure	to	
prevent	 the	 introduction	 and	 establishment	 of	 sustained	 transmis-
sion	across	 the	globe,	call	 for	a	 renewed	 focus	and	advancement	 in	
computational	approaches.	In	the	context	of	dynamic	modelling,	the	
literature	has	been	dominated	by	frameworks	based	on	ordinary	dif-
ferential	 equations	 (ODE),	 which	 are	 tractable	 and	 computationally	
inexpensive.	However,	 such	approaches	often	 take	key	assumptions	
unquestioningly,	such	as	homogeneous	mixing,	competition	factors	to	
desynchronize	antigenic	types,	or	continuity	and	determinism,	which	
can	hamper	our	understanding	of	the	major	determinants	of	dengue’s	
evolution,	epidemiology	and	control.	Within	a	multiscale	perspective	
on	 this	 biological	 system,	 and	with	 the	 aim	 of	 linking	 evolutionary,	
ecological	and	epidemiological	aspects	as	well	as	to	expand	on	classic	
modelling	assumptions,	we	here	propose,	discuss	and	exemplify	a	few	
major	 computational	 avenues,	which	we	hope	 should	offer	valuable	
research	opportunities	over	the	coming	years:	real-	time	computational	
analysis	of	genetic	data,	phylodynamic	modelling	frameworks,	within-	
host	model	frameworks	and	GPU-	accelerated	computing.
2.1 | Real- time collection and computational 
analysis of genetic data
Like	the	yellow	fever	virus	(Auguste,	Lemey,	Pybus,	Suchard,	&	Salas,	
2010),	DENV	was	probably	first	introduced	in	the	Americas	through	
infected	hosts	and	vectors	during	the	slave	trade	(Weaver	&	Vasilakis,	
2009;	 Vasilakis,	 &	 Weaver,	 2008).	 At	 present,	 the	 distribution	 of	
DENV	 serotypes	 results	 from	 a	 combination	 of	 strong	 population	
structure	and	gene	flow	across	geographical	regions.	South-	East	Asia	
harbours	 the	 greatest	DENV	genetic	 diversity,	 and	 it	 is	 from	 there	
that	viral	lineages	seem	to	seed	epidemics	in	the	Americas	and	else-
where	(Holmes,	2008).	Several	studies	suggest	that	every	7–10	years,	
DENV	genotypes	become	extinct	and	the	replacement	by	new	viral	
lineages	leads	to	period	fluctuations	in	genetic	diversity	(Klungthong,	
Zhang,	Mammen,	Ubol,	&	Holmes,	2004;	Thu,	Lowry,	Jiang,	Hlaing,	&	
Holmes,	2005;	Nunes,	Palacios,	Faria,	Sousa,	&	Pantoja,	2014).	Each	
of	these	epidemics	is	fuelled	by	a	combination	of	local	herd	suscepti-
bility	(Salje,	Lessler,	Endy,	Curriero,	&	Gibbons,	2012),	seasonal	abun-
dance	of	 the	Ae. aegypti	mosquito	 (Kraemer,	Sinka,	Duda,	Mylne,	&	
Shearer,	2015)	and	an	increasingly	well-	connected	mobility	network	
that	 facilitates	the	movement	of	 infected	hosts	and	vectors	 (Nunes	
et	al.,	 2014;	 Wesolowski,	 Qureshi,	 Boni,	 Sundsøy,	 &	 Johansson,	
2015).
Dengue	virus	 incidence	 is	 often	 underestimated	 and	 novel	 sur-
veillance,	tools	need	to	be	applied	to	improve	current	estimates	and	
reduce	misclassification	(Silva,	Rodrigues,	Paploski,	Kikuti,	&	Kasper,	
2016).	The	most	commonly	used	dengue	diagnostic	tests	are	based	
on	antibody	detection	and	often	show	cross-	reactivity	with	other	fla-
viviruses,	 including	West	Nile	virus,	Japanese	encephalitis	virus	and	
yellow	fever	virus.	Classification	based	on	clinical	symptoms	alone	is	
complicated	by	 the	 circulation	of	pathogens	 that	 cause	 similar	 clin-
ical	 symptoms	 to	 DENV	 infection,	 such	 as	 the	 chikungunya	 virus	
(CHIKV)	 and	 ZIKV,	 and	 may	 thus	 hamper	 accurate	 descriptions	 of	
DENV	 dynamics	 (Faria,	 Lourenço,	 Marques	 de	 Cerqueira,	 Maia	 de	
Lima,	&	Carlos	Junior	Alcantara,	2016;	Roth,	Mercier,	Lepers,	Hoy,	&	
Duituturaga,	2014).
One	of	the	ultimate	challenges	in	infectious	disease	control	 is	to	
predict	and	halt	 the	course	of	an	epidemic	 following	 its	emergence.	
However,	 insufficient	surveillance	can	obfuscate	predictions	of	virus	
dynamics	across	local,	regional	and	global	scales.	For	instance,	diagnos-
tic	tools	and	reporting	are	unevenly	supported	across	locations	with	
risk	for	transmission.	This	is	particularly	the	case	for	central	Africa,	for	
which	little	information	is	known	about	the	expansion	of	arboviruses	
(Jaenisch	 et	al.,	 2014),	 although	molecular	 detection	 from	 returning	
travellers	has	revealed	active	undetected	transmission	of	DENV	and	
CHIKV	in	this	region	(Parreira,	Centeno-	Lima,	Lopes,	Portugal-	Calisto,	
&	Constantino,	2014)	and	has	identified	it	as	the	source	of	the	CHIKV	
East-	Central-	South-	African	 genotype	 in	 the	 American	 continents	
(Nunes,	Faria,	de	Vasconcelos,	Golding,	&	Kraemer,	2015).	It	is	also	the	
case	that	representative	data	are	essential	to	quantify	the	burden	of	
transmission	and	to	predict	dynamic	behaviour	and	impact	of	interven-
tions	(Jaenisch	et	al.,	2014).	However,	even	in	regions	with	access	to	
diagnosis	and	surveillance,	it	is	rarely	the	case	that	reported	case	data	
on	arboviruses	are	representative	 (Silva	et	al.,	2016;	Lourenco,	Maia	
de	Lima,	Faria,	Walker,	&	Kraemer,	2017).	A	major	example	for	which	
both	of	these	issues	are	particularly	challenging	is	the	Amazon	region,	
that	 has	 been	 suggested	 to	 play	 a	 stepping	 stone	 role	 in	 the	 intro-
duction	of	DENV	lineages	from	the	Caribbean	into	Brazil	(Temporão,	
Penna,	Carmo,	Coelho,	&	Azevedo,	2011;	Nunes,	Faria,	Vasconcelos,	
de	Almeida	Medeiros,	&	de	Lima,	2012),	and	may	have	also	been	in-
volved	in	the	emergence	and	maintenance	of	ZIKV	(Faria,	Quick,	Claro,	
Thézé,	&	de	Jesus,	2017).
With	the	ongoing	democratization	of	pathogen	sequencing	(Faria,	
Sabino,	Nunes,	Alcantara,	&	Loman,	2016),	it	is	hoped	that	the	gener-
ation	of	genetic	data	will	soon	become	standard	in	public	health	and	
clinical	practise	(Houldcroft,	Beale,	&	Breuer,	2017).	Public	databases	
are	now	becoming	populated	with	thousands	of	partial	and	complete	
genome	 sequences.	 Sequencing	during	epidemics	 is	 even	becoming	
an	increasing	trend,	which	is	important	for	our	understanding	on	how	
particular	genotypes	associated	with	increased	virulence	may	be	gen-
erated	 and	eventually	 fixate	 (OhAinle,	Balmaseda,	Macalalad,	Tellez,	
&	Zody,	2011).	Moreover,	genetic	data	collected	over	 the	course	of	
months,	years	and	decades	allow	for	a	better	understanding	of	the	dy-
namics	of	DENV	lineages	at	the	population	level,	offering	key	insights	
into	demographic,	ecological	and	genetic	factors	which	are	difficult,	if	
not	impossible,	to	track	with	clinical	records	alone.
     |  7LOURENÇO Et aL.
With	the	real-time genomic epidemiology revolution	(Gardy,	Loman,	
&	 Rambaut,	 2015),	 new	 and	 complementing	 insights	 (to	 clinical	 re-
ported	case	data)	are	expected	to	provide	unique	information	about	
the	macro-	and	microscale	process	shaping	viral	dynamics.	Statistical	
models	 that	 take	 into	account	 shared	ancestry	allow	 testing	 for	 the	
contribution	of	demographic	factors	associated	with	virus	persistence	
and	spread	(Faria,	Suchard,	Rambaut,	Streicker,	&	Lemey,	2013;	Lemey,	
Rambaut,	Bedford,	Faria,	&	Bielejec,	2014).	Using	such	approaches,	air	
travel	has	been	shown	to	play	a	pivotal	role	in	the	spread	of	vectors	
(Tatem,	Hay,	&	Rogers,	2006)	and	DENV	(Nunes	et	al.,	2014).	Mobility	
may	also	play	a	significant	role	 in	the	spread	of	arboviruses	at	more	
local	scales;	for	example,	time	to	travel	has	been	shown	to	be	strongly	
associated	with	incidence	within	distinct	neighbourhoods	of	the	same	
city	during	an	arboviral	outbreak	(Faria,	Lourenço	et	al.,	2016).	As	real-	
time	collection	of	genetic	data	becomes	more	frequent	and	available,	
increased	 time	 and	 spatial	 resolution	will	 allow	 future	 phylogenetic	
and	modelling	studies	to	further	evaluate	the	relative	contribution	of	
short-	and	long-	distance	mobility.
It	 may	 seem	 that	 these	 recently	 established	 approaches	 and	
real-	time	 sequencing	 efforts	 are	more	 appropriate	 for	 emerging	 vi-
ruses,	such	as	ZIKV	or	the	Ebola	virus	(Faria	et	al.,	2017;	Woolhouse,	
Rambaut,	&	Kellam,	2015)	and	that	opportunities	have	been	missed	
in	the	context	of	DENV,	given	its	generalized	geographical	spread	and	
endemicity.	However,	major	 gaps	 in	our	 knowledge	 still	 exist	 in	 the	
context	of	DENV,	 sustained	by	 the	 insufficiency	of	 clinical	 reported	
case	counts.	 In	particular,	how	genotypes	manage	 to	persist	 in	 face	
of	significant	herd	immunity,	on	the	relative	role	of	urban	versus	rural	
spread	routes,	off-	season	persistence	and	on	the	invasion	and	emer-
gence	of	pathogenic	lineages	for	which	the	displacement	of	the	Asian/
American	by	the	Asian-	1	type	 in	South-	East	Asia	 is	a	good	example	
(Lourenço	 &	 Recker,	 2010;	 Hang,	 Holmes,	 Duong,	 Nguyen,	 &	Tran,	
2010).	Hence,	while	 the	endemic	state	of	DENV	may	render	efforts	
of	real-	time	sequencing	less	appealing,	we	argue	that	the	enumerated	
knowledge	gaps	offer	major	research	opportunities.	It	is	also	the	case	
that	retrospective	analysis	of	archived	clinical	samples,	such	as	blood	
banks,	 could	 contribute	 massively.	 However,	 real-	time	 sequencing	
not	only	offers	 the	same	opportunities	as	 retrospective	approaches,	
as	it	also	renders	timely	interventions	possible	with	significant	public	
health	impact,	for	instance	in	face	of	emerging	virulent	genotypes	or	
introduction	of	serotypes	which	may	increase	the	number	of	heterol-
ogous	challenges.
2.2 | Phylodynamic modelling frameworks
The	genetic	diversity	of	RNA	viruses	is	shaped	in	direct	response	to	
changes	in	host	and	vector	demographic	and	ecological	factors,	such	
as	 population	 size,	 structure	 or	 movement.	 This	 provides	 measur-
able	connections	between	host	population	dynamics,	viral	evolution	
and	transmission.	In	recent	years,	genetic,	immunological	and	epide-
miological	data	have	been	successfully	used	to	investigate	such	con-
nections,	 unifying	 key	 observations	 across	 biological	 scales	 within	
a	 single	 framework	 known	 as	 phylodynamics	 (Grenfell	 et	al.,	 2004;	
Volz,	 Koelle,	 &	 Bedford,	 2013).	However,	while	 some	 studies	 have	
addressed	dengue’s	epidemiology	 in	 the	context	of	a	phylodynamic	
framework	(Rasmussen,	Boni,	&	Koelle,	2014;	Ke,	Aaskov,	Holmes,	&	
Lloyd-	Smith,	2013),	integrative	modelling	approaches	in	which	trans-
mission	models	are	used	to	simulate	both	the	epidemiology	and	mo-
lecular	evolution	of	the	virus	have	not	yet	been	applied	to	dengue.
Dengue	virus	 is	 a	 surprisingly	 conserved	RNA	virus	 (Choudhury,	
Lott,	Banu,	Cheng,	&	Teo,	2015;	Lequime,	Fontaine,	Ar	Gouilh,	Moltini-	
Conclois,	 &	 Lambrechts,	 2016;	Thai,	Henn,	 Zody,	Tricou,	&	Nguyet,	
2012;	Amarilla,	de	Almeida,	Jorge,	Alfonso,	&	de	Castro-	Jorge,	2009;	
Holmes,	2003).	Even	though	its	serotypes	present	seemingly	compet-
itive	dynamics,	 similar	 to	 the	behaviour	of	antigenic	strains	of	other	
fast	 evolving	 pathogens,	 observations	 of	 positive	 selection	 are	 rare	
(Tang	et	al.,	2010;	Filomatori	et	al.,	2017;	Waman	et	al.,	2016;	Hang	
et	al.,	2010;	Choudhury	et	al.,	2015;	Martin,	Chirivella,	Co,	Santiago,	
&	Gubler,	2016;	Sim,	Aw,	Wilm,	Teoh,	&	Hue,	2015).	Dengue	trans-
mission	models	have	offered	 insight,	but	have	so	 far	 failed	 to	 reach	
consensus	on	the	possible	biological	drivers	of	the	observed	dynamic	
behaviour.	 For	 other	 pathogens,	 such	 as	 influenza	A,	 phylodynamic	
transmission	models	have	allowed	to	filter	out	a	wide	range	of	hypoth-
eses	regarding	potential	drivers	(e.g.,	Bedford,	Suchard,	Lemey,	Dudas,	
&	 Gregory,	 2014;	Minayev	 &	 Ferguson,	 2009),	 as	 model	 validation	
becomes	stricter	and	requires	both	epidemiological	and	evolutionary	
trajectories	to	match	observed	data	patterns.
Here,	we	argue	that	phylodynamic	models	could	offer	critical	 in-
sight	into	currently	open	questions	on	dengue’s	evolution	and	epide-
miology,	for	example	by	assessing	what	assumptions	about	serotype	
immune	interactions	are	compatible	with	empirical	population	genetic	
and	phylogenetic	data,	 similar	 to	approaches	applied	 to	 influenza	A.	
This	approach	is	exemplified	in	Box	I,	where	we	extended	a	previously	
published,	 individual-	based	dengue	 transmission	model	 (Lourenço	&	
Recker,	2013)	 to	 include	explicit	molecular	evolution.	Two	scenarios	
are	compared:	one	in	which	the	dynamics	and	evolutionary	histories	
are	purely	driven	by	demographic	and	transmission	processes	without	
immune	interactions	(Box	I,	a–d),	and	one	where	we	considered	tem-
porary,	 serotype-	transcending	 immunity	 following	 recovery	 from	 in-
fection	(Box	I,	e–f).	With	this	approach,	the	phylogenetic	output	would	
be	particularly	 informative	 as	 cross-	immunity	 results	 in	more	 imbal-
anced	phylogenetic	trees,	akin	to	a	ladder-	like	topology	that	is	often	
reported	for	other	pathogens,	such	as	influenza	A	(Bedford	et	al.,	2014;	
Bedford,	Cobey,	&	Pascual,	 2011)	or	within-	host	HIV	 (Shankarappa,	
1999),	where	cross-	immunity	is	known	to	play	a	crucial	role.
Given	 seasonal	 epidemic	 troughs	 in	 endemic	 regions,	 possible	
mechanisms	 for	viral	 persistence	 are	 still	 open	 topics	 of	 discussion,	
in	particular	as	phylogenetic	studies	have	shown	that	the	lack	of	case	
reports	 can	 be	 followed	 by	 resurgence	 of	 previously	 circulating	 ge-
netic	variants	(Bennett	et	al.,	2003,	2010;	Carrington,	Foster,	Pybus,	
Bennett,	&	Holmes,	2005).	Persistence	may	be	achieved	by	a	combi-
nation	of	temporary	circulation	in	the	vector	population	(i.e.,	vertical	
transmission)	(Bosio,	Thomas,	Grimstad,	&	Rai,	1992;	Adams	&	Boots,	
2010),	 an	 unknown	 reservoir	 (Weaver	 &	 Vasilakis,	 2009;	 Vasilakis,	
Cardosa,	Hanley,	Holmes,	&	Weaver,	2012),	silent	transmission	(Kyle	&	
Harris,	2008;	Morrison	et	al.,	2010;	Poblap,	Nitatpattana,	Chaimarin,	
Barbazan,	&	Chauvancy,	2006),	or	may	 simply	be	a	 consequence	of	
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reintroduction	from	nearby	regions	following	local	extinction.	The	par-
ticular	hypothesis	of	continuous	silent	transmission	is	critical	for	public	
health,	while	the	possibility	of	exogenous	circulation	has	severe	impli-
cations	for	control.	Box	I	shows	that	viral	diversity	can	be	addressed	
in	phylodynamic	models,	which	 is	seen	to	respond	both	to	seasonal	
troughs	and	to	natural	fluctuations	in	serotype	prevalence.	Diversity	
can	 be	 expected	 to	 behave	 differently,	 for	 example	 depending	 on	
whether	 exogenous	 reservoirs	 are	 considered	or	 not.	 Phylodynamic	
models	could	thus	be	used	to	explore	hypotheses	on	mechanisms	of	
(local)	viral	persistence	in	ways	not	possible	with	current	transmission	
models	and	may	 therefore	change	our	current	understanding	of	 the	
persistence	of	dengue	viruses.
Box I Phylodynamic modelling
The	explicit	modelling	of	molecular	evolution	allows	for	an	exploration	of	dengue’s	drivers	for	key	observations	of	phylogenetics	and	popula-
tion	genetics,	such	as	tree	imbalance,	Tajima	D	and	measures	of	viral	diversity.	Here,	 in	order	to	 illustrate	such	potential,	we	expand	an	
individual-	based	framework	to	include	the	transmission	and	evolution	of	individual	virions.	We	make	a	number	of	simplifying	assumptions:	
one	virion	is	modelled	per	host;	the	transmission	chain	of	a	single	serotype	is	used	to	define	the	discrete	birth–death	process	of	virions;	
mutation	occurs	over	the	birth–death	process,	resulting	in	a	multichotomous,	evolution	tree;	a	fixed	molecular	clock	is	used	for	the	muta-
tional	 input,	which	 follows	 an	 infinite-	sites	model	with	no	 recombination;	 all	mutations	 are	 assumed	 to	be	neutral;	 a	 burn-	in	period	of	
25	years	for	transmission	(ending	at	t = 0	in	figures),	followed	by	10	years	for	molecular	evolution	(t = 10),	is	considered	before	model	output	
is	recorded;	a	single	founder	virus	is	used	(t = 0);	population	genetic	sampling	is	uniform	in	time-	and	frequency-	dependent;	phylogenetic	tree	
is	a	small	sample	(<1%)	of	the	evolution	tree.
(a) (b) (e)
(c) (d) (f)
These	figures	present	the	dynamic	potential	of	an	individual-	based	model	with	explicit	molecular	evolution.	In	figures	a–d,	the	complete	
model	output	shows	how	demographic	stochasticity	and	the	mechanics	of	transmission	alone	can	dictate	the	intrinsic	behaviour	of	viral	di-
versity	and	phylogenetic	shape.	In	contrast,	figures	e	and	f	show	how	such	signatures	(e.g.	phylogentic	shape)	can	be	significantly	altered	
when	changing	model	assumptions—in	this	particular	case,	the	addition	of	a	9-	month	period	of	transcending,	cross-	protective	immunity.
(a,	 b,	 c,	 d)	Model	 output	without	 considering	 serotype-	immune	 interactions.	 (e,	 f)	Model	 output	with	 9	months	 of	 transcending	 cross-	
immunity.	A	particular	serotype	(DENV1,	orange)	is	chosen	for	the	population	genetics	and	phylogenetic	output.	Effective	population	size	is	
considered	to	be	the	total	number	of	virions	of	the	chosen	serotype.	Some	output	variables	are	normalized	between	0	and	1	for	visualization	
purposes.	(a	and	e)	Dynamics	of	the	four	serotypes.	(b)	Tajima	D	(magenta)	and	effective	population	size	(orange).	(c)	Number	of	segregating	
sites	(light	blue),	sequence	pairwise	diversity	(dark	blue)	and	effective	population	size	(orange).	(d	and	f)	Phylogenetic	three	with	tips	coloured	
according	to	accumulated	number	of	mutations	(tips	are	sampled	after	the	10	year	burn-	in).
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In	a	broader	evolutionary	perspective,	drivers	of	key	observations	
on	 the	molecular	 evolution	 of	 dengue	 could	 also	 be	 studied	within	
these	frameworks.	For	 instance,	strong	purifying	selection	 is	consis-
tently	 reported	 in	 sequence	data,	 for	which	 it	 is	 generally	 accepted	
that	the	two-	host	 life	cycle	imposes	strong	evolutionary	constraints.	
Box	I	 (b)	 shows,	 however,	 that	 even	without	 explicit	 constraints	 on	
molecular	evolution	(e.g.,	deleterious	mutations),	negative	Tajima	D,	a	
proxy	for	purifying	selection,	is	self-	emergent.	As	such,	demographic	
and	 transmission	 processes	 appear	 sufficient	 to	 maintain	 the	 viral	
population	as	under	purifying	selection.	Sensitivity	experiments	could	
therefore	be	used	to	test	which	processes	seem	to	dictate	these	pop-
ulation	genetic	signatures;	for	example,	how	does	host	mixing	in	terms	
of	mobility	or	patch	organization	alter	such	observations?
There	are	also	reports	of	sporadic	episodes	of	positive	selection	
and	fixation	of	particular	lineages	(Tang	et	al.,	2010;	Filomatori	et	al.,	
2017;	Waman	et	al.,	2016;	Hang	et	al.,	2010;	Choudhury	et	al.,	2015;	
Martin	et	al.,	2016),	and	 it	 is	generally	believed	that	most	events	of	
lineage	replacement	go	unnoticed,	as	the	majority	of	endemic	regions	
rely	on	syndromic	surveillance,	and	as	these	events	are	not	expected	
to	 result	 in	 significant	 changes	 in	 disease	 incidence	 (Lourenço	 &	
Recker,	 2010).	While	 there	 are	 rare	 examples	 of	well-	described	 lin-
eage	 shifts	 in	 the	 literature	 (OhAinle	 et	al.,	 2011;	 Bennett,	Holmes,	
Chirivella,	Rodriguez,	&	Beltran,	2006),	not	much	is	known	about	the	
epidemiological	and	ecological	contexts	in	which	emergence	of	fitter	
lineages	is	favoured.	Our	previous	work	has	suggested	that	stochastic	
effects	and	clonal	 interference	are	major	determinants	of	 the	emer-
gence	of	fitter,	potentially	more	virulent	variants	(Lourenço	&	Recker,	
2010).	With	these	more	detailed	individual-	based	model	frameworks,	
the	strength	of	such	determinants	could	be	tested	with	higher	resolu-
tion,	discerning,	 for	 instance,	between	stochastic	pressures	dictated	
by	population	structure,	host	mixing	or	spatial	heterogeneity	in	herd	
immunity	(Lourenço	&	Recker,	2013).
Disparate	levels	of	within-	and	between-	host	genetic	diversity	are	
a	common	feature	of	DENV	viruses,	and	complementary	hypotheses	
exist	 for	 these	observations	 (Choudhury	et	al.,	2015;	Lequime	et	al.,	
2016;	Thai	et	al.,	 2012).	By	allowing	parameterization	of	mutational	
input	 and	 quantification	 on	 how	 population-	level	 events	 modulate	
within-	host	genetic	diversity,	phylodynamic	models	could	help	make	
predictions	 on	 the	 relative	 contribution	 of	 different	mechanisms.	 In	
particular,	 transmission	bottlenecks	could	be	 implemented	and	their	
effect	tested	in	the	background	of	cross-	immunity	and	clonal	interfer-
ence	(Lourenço	&	Recker,	2010).
There	are	concerns	related	to	viral	escape	variants	following	inter-
vention	programmes	based	on	vaccination	and/or	Wolbachia-	infected	
mosquitoes.	While	 for	Wolbachia-	based	control	strategies,	 it	can	be	
argued	that	these	concerns	are	so	far	theoretical	(Bull	&	Turelli,	2013),	
escape	in	a	postvaccination	era	has	been	reported	for	a	wide	range	of	
pathogens	(Read,	Baigent,	Powers,	Kgosana,	&	Blackwell,	2015;	Pérez-	
Sautu,	Costafreda,	Caylà,	Tortajada,	&	Lite,	2011).	The	explicit	gener-
ation,	 emergence	 and	 spread	of	 escape	mutants	 could	 be	modelled	
within	phylodynamic	frameworks	such	as	the	one	presented	in	Box	I,	
given	 that	 individual	 mutations	 are	 already	 tracked.	Vaccination,	 as	
demonstrated	in	previous	work,	can	also	be	easily	included	(Lourenço	
&	Recker,	 2016;	 Flasche	 et	al.,	 2016).	 Parameterization	 on	 the	 effi-
ciency	of	viral	 escape	 to	vaccine-	induced	 immunity	would	 allow	 for	
sensitivity	experiments	and	projections	on	the	public	health	impact	of	
such	escape	variants.	Furthermore,	demographic	and	ecological	het-
erogeneities	could	also	be	researched,	such	as	population	structure,	
in	order	to	evaluate	under	which	conditions	such	variants	could	more	
easily	emerge	and	devise	appropriate	intervention	schemes	that	could	
stop	their	fixation.
Finally,	 as	described	 in	 the	previous	 section,	 real-	time	collection	
and	 analysis	 of	 genetic	 data	 will	 soon	 offer	 vast	 amounts	 of	 high-	
resolution	 data	 on	 population	 genetic	 measurements	 and	 phyloge-
netics,	 both	 in	 time	 and	 space.	 This	will	 fundamentally	 change	 our	
perspective	 and	 the	 number	 of	 empirical	 observations	 that	 can	 be	
used	to	validate	model	frameworks.	The	use	of	more	complex	mod-
elling	approaches,	such	as	individual-	based	models,	including	atypical	
dimensions	 such	as	detailed	 spatial	 scales	 (Box	II)	or	molecular	evo-
lution	 (Box	I),	will	not	only	be	a	valuable	path	of	research,	but	could	
indeed	 become	 necessary	 approaches	 to	 be	 able	 to	match	 the	 rich	
variety	of	observed	data	patterns	across	biological	scales.
2.3 | Within- host models
The	 vast	majority	 of	 dengue	models	 has	 focused	on	 viral	 dynamics	
at	 the	 population-	level.	 Given	 the	 importance	 that	 the	 within-	host	
processes	 (e.g.,	 ADE	 and	 cross-	immunity)	 play	 for	 both	 viral	 trans-
mission	 and	disease	pathology,	 it	 is	 thus	 surprising	 that	 just	 over	 a	
handful	 of	 studies	 have	 so	 far	 investigated	 viral	 dynamics	 at	 the	
within-	host	level	(Nuraini,	Tasman,	Soewono,	&	Sidarto,	2009;	Ansari	
&	 Hesaaraki,	 2012;	 Clapham,	 Tricou,	 N.	 V.,	 Simmons,	 &	 Ferguson,	
2014;	Ben-	Shachar	&	Koelle,	2014;	Gujarati	&	Ambika,	2014;	Nikin-	
Beers	&	Ciupe,	2015;	Clapham,	Quyen,	Kien,	Dorigatti,	&	Simmons,	
2016;	Ben-	Shachar,	Schmidler,	&	Koelle,	2016).	This	could,	however,	
be	explained	by	the	little	understanding	we	currently	have	about	the	
interactions	between	the	virus,	 its	target	cells	and	the	host	 immune	
responses	that	eventually	clear	infection,	which	may	also	be	directly	
responsible	for	clinical	outcome.
The	 target	 cell	 population	 for	 DENV	 replication	 is	 still	 not	well	
characterized	 in	vivo,	although	 in	vitro	studies	strongly	suggest	 that	
monocytes,	dendritic,	 endothelial	 and	epithelial	 cells	 are	 among	 the	
preferential	 targets	of	 infection	 (Fernandez-	Garcia	et	al.,	2009;	Ubol	
&	 Halstead,	 2010;	 Dejnirattisai	 et	al.,	 2010;	 Katzelnick,	 Coloma,	 &	
Harris,	 2017).	 Similarly,	 it	 has	 been	 demonstrated	 that	 both	 innate	
and	adaptive	immune	responses	play	a	role	during	infection,	but	it	is	
not	well	understood	how	these	can	mechanistically	and	synergistically	
achieve viral clearance.
There	 are	 two	 main	 known	 mechanisms	 of	 antibody	 action	 for	
viral	 clearance	 in	 dengue	 infection—antibodies	 can	 indirectly	 act	 to	
clear	infected	cells	via	antibody-	dependent	cell-	mediated	cytotoxicity	
(ADCC),	or	directly	by	neutralization.	A	data-	driven	study	by	Clapham	
et	al.	 (2016)	 focused	 on	 the	 distinction	 between	 these	 two	mecha-
nisms	and	found	that	either	could	explain	the	data	(viral	and	antibody	
titres)	equally	well.	Two	other	studies	have	focused	on	the	general	me-
chanics	of	humoral	responses	(B	cell	and	free	antibody)	using	different	
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Box II Sensitivity analysis using GPU acceleration
The	increased	computational	power	due	to	GPU	parallelization	permits	a	deeper	exploration	into	the	epidemiological	effects	of	different	community	
structures,	vector	and	host	heterogeneities,	environmental	heterogeneities	or	human	movement	patterns.	Here,	in	order	to	illustrate	the	use	of	GPU-	
accelerated	agent-	based	modelling,	we	investigate	how	the	connectivity	between	subpopulations,	as	a	proxy	for	human	movement/major	commuting	
patterns,	affects	the	epidemiological	dynamics	of	dengue	within	a	spatial	meta-	population	model.	In	this	framework,	the	population	(human	and	mosqui-
toes)	is	divided	into	subpopulations	and	arranged	spatially	into	a	network	of	communities,	connected	by	major	trade	and/or	commuting	routes.	Dengue	
transmission	events	are	dispersed	through	the	network	predominantly	via	local	connections	between	communities	as	well	as	occasional	but	random	
transmission	events	between	distant	(i.e.,	not	directly	connected)	subpopulations.	The	global	connectivity	pattern	can	then	be	quantified	by	means	of	the	
network’s	degree bias,	which,	in	its	simplest	form,	can	be	interpreted	as	the	number	of	nodes	(i.e.,	communities)	that	are	only	connected	to	one	other	node.
Plots	a–b	show	two	examples	of	networks	with	either	a	low	or	a	high	degree	bias,	respectively.	As	can	be	seen	in	the	corresponding	time	
series	of	serotype-	specific	incidence,	the	way	that	communities	are	connected	to	form	a	meta-	population	has	a	strong	effect	on	the	epide-
miological	dynamics,	especially	with	respect	to	the	interannual	variability	and	serotype	periodicity.	This	can	be	further	illustrated	by	means	
of	a	sensitivity	analysis,	where	we	gradually	increased	the	degree	bias	and	recorded	the	model’s	relative	change	in	four	characteristic	epide-
miological	and	serotype-	specific	measures	(plots	c–d).	In	this	specific	example,	where	we	considered	a	population	size	of	5	million	humans	
and	up	to	6	million	mosquitoes,	we	gained	a	speed-	up	of	around	320	(using	a	Nvidia	GTX	1070	graphics	card).	In	other	words,	running	the	
same	analysis,	which	took	just	over	9	hr	to	complete,	would	have	taken	about	4	months	on	a	single	core	CPU	and	still	many	weeks	using	
multithreaded	CPU	computing	on	a	high-	end	PC.	This	clearly	illustrates	how	GPU-	based	computing	may	facilitate	the	use	of	bigger	and	more	
complex	models	for	addressing	some	of	the	outstanding	dengue	epidemiological	and	evolutionary	questions	discussed	in	this	work.
(a)
(b)
(c) (d)
(a,	 b)	 The	 degree	 of	 connectivity	 between	 subpopulations	 has	 a	 strong	 effect	 on	 the	 epidemiological	 dynamics	 of	 dengue.	 (c,	 d)	Model	
	sensitivity	analysis	showing	the	relative	change	in	epidemiological	and	serotype-	specific	characteristics	depending	on	the	network’s	degree	
bias.	Each	point	is	the	result	of	50	model	runs	over	a	100-	year	period,	with	error	bars	depicting	the	standard	error.
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modelling	frameworks	(Gujarati	&	Ambika,	2014;	Nikin-	Beers	&	Ciupe,	
2015).	While	one	 study	concluded	 that	enhancing	antibodies	 (ADE)	
were	key	in	secondary	infections	(Gujarati	&	Ambika,	2014),	the	other	
study	suggested	instead	a	direct	decrease	of	overall	heterologous	viral	
clearance,	whereby	 cross-	reactive	 antibodies	 render	virions	 unavail-
able	 for	 further	binding	 and	 subsequent	 clearance	by	ADCC	 (Nikin-	
Beers	&	Ciupe,	2015).	 In	another	study,	the	question	about	the	role	
of	the	adaptive	and	innate	immune	responses	in	disease	severity	was	
addressed	 (Ben-	Shachar	 &	 Koelle,	 2014;	 Ben-	Shachar	 et	al.,	 2016).	
It	was	 shown	 that	 characteristic	 features	of	primary	 infection	 could	
be	 replicated	 solely	 by	 innate	 immune	 responses	 (NK	 cells).	 In	 con-
trast,	features	of	secondary	infection,	including	ones	related	to	clini-
cal	outcome,	required	greater	infectivity	rates	(ADE)	together	with	T	
cell-	mediated	clearance	of	infected	cells	in	a	process	arguably	similar	
to	well-	described	cytokine	storms	 (Rothman,	2011;	Katzelnick	et	al.,	
2017).	 In	 line	with	previous	 results	by	Clapham	et	al.	 (2014),	 it	was	
proposed	 that	 the	observed	variations	 in	viral	 load	 could	 largely	 be	
explained	by	assuming	patient-	specific	incubation	periods.
Generally	and	similarly	to	the	aforementioned	discrepancy	between	
model	assumptions	related	to	immune	interactions	at	the	population	
level,	within-	host	approaches	have	been	able	 to	 replicate	 important	
and	ubiquitous	data	patterns,	but,	either	due	to	formalism	or	data	re-
strictions,	have	been	limited	in	establishing	a	consensus	framework.	In	
some	cases,	the	models	and	the	data	sets	differed,	making	it	hard	to	
assess	whether	contrasting	conclusions	are	data-	or	model-	driven.	For	
instance,	some	models	propose	a	key	role	of	innate	immunity	in	clear-
ance	of	primary	infection	(Ben-	Shachar	&	Koelle,	2014;	Ben-	Shachar	
et	al.,	2016),	while	others	propose	that	either	humoral	or	cell-	mediated	
clearance	is	required	(Nuraini	et	al.,	2009;	Ansari	&	Hesaaraki,	2012;	
Clapham	et	al.,	2014;	Gujarati	&	Ambika,	2014;	Nikin-	Beers	&	Ciupe,	
2015;	Clapham	et	al.,	2016).	Equally,	asymmetries	between	serotypes	
in	both	cell	infectivity	and	timing	of	peak	viraemia	versus	symptomatic	
manifestations	were	reported	in	one	study	(Ben-	Shachar	et	al.,	2016)	
but	not	in	another	(Clapham	et	al.,	2014).
A	current	major	problem	is	the	lack	of	fine-	scaled	data	that	cap-
tures	the	early,	prepeak	infection	dynamics.	This	issue	arises	from	the	
self-	limiting	nature	of	dengue	infections,	fast	viral	clearance	rates	and	
the	 absence	of	 antiviral	 therapies	 against	 dengue,	which	 effectively	
prevent	human	infection	studies.	In	fact,	antiviral	therapy	has	been	de-
valued	due	to	the	fact	that	the	timing	of	clinical	symptoms	often	over-
laps	with	peak	viral	load	(Clapham	et	al.,	2014);	that	is,	most	patients	
will	seek	treatment	at	a	point	when	the	virus	is	already	being	cleared	
by	the	 immune	system.	However,	 in	another	example	of	contrasting	
observations,	 if	there	are	indeed	significant	differences	between	the	
serotypes,	 as	 suggested	 by	 Ben-	Shachar	 et	al.	 (Ben-	Shachar	 et	al.,	
2016),	 then	there	might	be	a	question	whether	sero-	specific	strate-
gies	could	be	beneficial,	for	which	modelling	studies	could	contribute	
useful	answers.
Another	 promising	 avenue	 is	 in	 the	 context	 of	 vaccination.	
Recently,	 the	 first	 dengue	 vaccine	 was	 licensed	 (Dengvaxia®)	 and	
many	others	are	in	advanced	trial	stages	(Schmitz,	Roehrig,	Barrett,	&	
Hombach,	2011;	Thomas	&	Endy,	2011;	Schwartz,	Halloran,	Durbin,	
&	 Longini,	 2015).	 For	 a	 good	 number	 of	 these,	 data	 will	 be	 made	
available	on	population-	level	efficacy	but	also	on	within-	host	markers	
and	dynamic	measurements	of	 infection	and	 immune	response	 (e.g.,	
Dorigatti,	Aguas,	Donnelly,	Guy,	&	Coudeville,	2015).	Such	data	can	be	
used	to	 inform	new	modelling	frameworks	to	explain	vaccine	action	
(e.g.,	infection	versus	transmission	blocking),	which	may	have	consid-
erable	impact	on	licensing	and	future	distribution.	We	note,	however,	
that	is	yet	unknown	whether	fine-	scale	kinetic	data	will	be	available,	
which	is	essential	to	parameterize	models	(Magnus,	2013)	and	to	add	
insight	into	current	knowledge	gaps	on	the	fast	kinetics	of	the	virus,	
in	particular	during	 the	 initial	phase	of	 infection.	Finally,	 and	 similar	
to	between-	host	models,	within-	host	models	of	dengue	have	so	 far	
only	considered	a	single	ecological	scale.	With	the	advent	of	models	
with	better	computational	implementation	(see	next	section),	both	the	
between-	host	and	within-	host	dynamics	 could	be	 integrated	 in	uni-
fied,	multiscale	frameworks.	These	could	be	used	to	investigate	how	
assumptions	about	viral	dynamics	and	immune	kinetics,	together	with	
individual-	level	 variations	 and	 transmission	 mechanics,	 would	 influ-
ence	epidemiological	and	evolutionary	observations	at	the	population	
level	(Box	I).
2.4 | GPU modelling frameworks
Many	 traditional	 approaches	 in	 theoretical	 epidemiology	 of	 dengue	
and	other	infectious	diseases	rely	on	mass-	action	principles	whereby	
the	rate	at	which	a	disease	spreads	through	a	population	 is	directly	
proportional	to	either	the	number	or	the	proportion	of	infected	and	
susceptible	 individuals	within	 that	population.	Under	 these	assump-
tions,	 every	 individual	 has	 the	 same	probability	 of	 getting	 infected,	
contributes	equally	to	disease	transmission	and	recovers	at	the	same	
rate	as	everyone	else.	Their	low	computational	footprint	and	analytical	
tractability	make	these	models	an	attractive	choice	for	 investigating	
population-	level	dynamical	behaviours,	especially	when	homogeneity	
in	time	and	space	can	safely	be	assumed.	In	many	cases,	this	cannot	
be	guaranteed,	however,	and	individual	variations,	arising	through	the	
stochastic	 nature	 of	 infection	 events,	 for	 example,	 or	 through	 eco-
logical	and	demographic	heterogeneities,	cannot	be	captured	by	these	
models	and	require	a	different	approach	altogether.
Agent	 or	 individual-	based	 models	 offer	 a	 natural	 and	 intuitive	
way	 to	 account	 for	 these	 variations	 by	 keeping	 track	 of	 individual,	
probabilistic	 infection	 events	 in	 both	humans	 and	mosquito	vectors	
and	have	been	implemented	to	various	degrees	of	realism	and	model	
complexity.	As	an	example,	 spatial	 details	 can	be	 included	by	divid-
ing	the	population	into	smaller	subpopulations	arranged	in	a	rectan-
gular	 grid	 (see	Figure	3).	This	 approach	has	already	highlighted	how	
the	spatial	segregation	of	individuals,	causing	stochastic,	local	extinc-
tion	and	 re-	invasion,	can	explain	much	of	dengue’s	observed	epide-
miology	(Lourenço	&	Recker,	2013).	Further	detail	may	be	introduced	
by	 adding	more	 realistic	 spatial	 arrangements	by	means	of	 complex	
networks	with	 nodes	 representing	 villages	 or	 cities	 and	 edges	 rep-
resenting	 their	 connecting	 trade	or	 commuting	 routes,	 for	 example.	
Subpopulations	can	further	be	divided	to	take	into	account	individual	
households,	work	places	or	schools,	as	well	as	the	human	movement	
patterns	between	them	(see,	e.g.,	(Chao,	Halstead,	Halloran,	&	Longini,	
12  |     LOURENÇO Et aL.
2012;	Karl,	Halder,	Kelso,	Ritchie,	&	Milne,	2014;	Perkins,	Garcia,	Paz-	
Soldán,	Stoddard,	&	Reiner,	2014)).	In	fact,	the	explicit	description	of	
each	individual	(human	and	vector),	together	with	their	ecological	and	
socio-	demographic	interactions,	allows	a	near	limitless	level	of	spatio-	
temporal	detail	to	be	incorporated	into	these	models.
The	 inclusion	 of	 (every)	 minute	 detail	 comes	 at	 the	 cost	 of	
computational	feasibility	and	generalizability,	however.	That	is,	the	
computational	 demands	 imposed	 by	 an	 increase	 in	 model	 com-
plexity,	 due	 to	 the	 incorporation	 of	 more,	 and	more	 detailed	 in-
formation	 of	 individual-	level	 behaviours,	 can	 quickly	 exceed	 the	
capabilities	of	modern-	day	personal	computers	and	require	either	
very	 long	 run-	times	 or	 the	 implementation	 on	 high-	performance	
computer	 clusters.	 Furthermore,	 the	 limited	 availability	 of	 fine-	
scaled	data	necessary	to	parameterize	these	models	often	restricts	
their	use	 to	 the	 investigation	of	particular	 aspects	of	dengue	ep-
idemiology	 and	 mostly	 in	 one	 specific	 setting.	 Results	 obtained	
from	 these	 studies,	 although	highly	 informative	 for	 the	particular	
research	 question,	 are	 therefore	 not	 easily	 transferable	 to	 other	
epidemiological	or	geographical	settings.	This	then	implies	that	for	
research	 questions	 of	 a	more	 general	 nature	 a	 balance	 needs	 to	
be	struck	between	a	model’s	biological	and	ecological	realism	and	
computational	feasibility.
In	many	cases,	the	computational	overhead	of	agent-	based	mod-
els	arises	not	necessarily	 from	 individual	 infection	events	but	 rather	
from	keeping	track	of	host	and	vector	demography	and	ecology,	 for	
example	the	processes	related	to	birth,	death	and	ageing.	As	these	are	
largely	independent	events,	they	are	amenable	to	code	parallelization	
and	can	thus	benefit	from	graphics	processing	unit	(GPU)	acceleration,	
which	specializes	in	attaining	high	arithmetic	throughputs.	Speed-	ups	
of	anywhere	between	10	and	1000	times	from	a	serialized	central	pro-
cessing	unit	(CPU)	code	are	theoretically	feasible,	although	in	practice	
this	very	much	depends	on	the	particular	model	and	implementation.	
That	 is,	 the	 benefits	 of	 GPU	 acceleration	 can	 easily	 get	 lost	 on	 in-
creasingly	refined	spatial	resolutions,	for	example,	when	more	time	is	
spent	keeping	track	of	individuals’	movements	(which	is	generally	not	
parallelizable)	 than	updating	 infection	statuses	or	age.	Nevertheless,	
the	gain	in	computational	speed-	up	through	GPU	acceleration	enables	
us	to	simulate	much	bigger	and	more	detailed	models	in	significantly	
less	time	(see	Box	II).
The	necessity	to	include	higher-	resolution	in	biological	scales	such	
as	population	structure	in	modelling	frameworks	is	clear,	given	the	re-
cent	rise	of	ever	more	detailed	genetic	(Faria	et	al.,	2017;	Woolhouse	
et	al.,	 2015),	 mobility	 (Kraemer,	 Perkins	 et	al.,	 2015;	 Wesolowski	
et	al.,	 2015;	 Lemey	 et	al.,	 2014)	 or	 social/communication	 (Salathé,	
Bengtsson,	Bodnar,	Brewer,	&	Brownstein,	 2012)	 data	 sets.	That	 is,	
the	increased	difficulties	 (e.g.,	 interpretation)	arising	from	the	use	of	
more	complex	models	were	not	compensated	for	by	sufficient	data	to	
validate	model	output;	however,	this	is	now	changing.	Methodologies	
such	as	the	one	presented	in	Box	II	now	offer	major	opportunities	to	
test	and	create	new	hypotheses	on	the	spread,	evolution	and	control	
of	communicable	diseases.
The	spatial	 resolution	of	 the	research	question	dictates	the	com-
plexity	level	of	community	structuring	required	in	a	model.	Nonspatial	
deterministic	approaches	provide	a	natural	entry	point	in	understand-
ing	the	epidemiology	of	pathogens	strictly	across	time	(Nagao	&	Koelle,	
2008;	 Rodriguez-	Barraquer,	 Mier-	y	 Teran-	Romero,	 Schwartz,	 Burke,	
&	Cummings,	2014;	Ferguson,	Rodríguez-	Barraquer,	Dorigatti,	Mier-	y	
Teran-	Romero,	 &	 Laydon,	 2016).	 Epidemiological	 questions	 directed	
over	 very	 small	 geographical	 areas,	 such	 as	 investigating	 the	 effects	
of	vector	distribution,	or	vector	and	host	movement	between	an	indi-
vidual’s	home	and	workplace,	require	fine-	scale	spatial	models	(Chao,	
Longini,	&	Halloran,	2013;	Reiner,	Stoddard,	&	Scott,	2014;	Perkins,	Paz-	
Soldan,	Stoddard,	Morrison,	&	Forshey,	2016;	Hladish,	Pearson,	Chao,	
Rojas,	&	Recchia,	 2016).	Coarser-	scaled	 network	models	 are	 applied	
when	individual	movement	between	households	becomes	redundant,	
for	example	exploring	 the	effects	of	national	or	 international	human	
movement,	or	environmental	heterogeneities	over	large	spatial	regions,	
on	the	spread,	evolution	and	control	of	communicable	diseases.
In	 the	 context	 of	 DENV,	 such	 approaches	 are	 now	 reaching	
the	 capacity	 to	 be	modulated	 and	 fitted	 to	 particular,	 existing	 host	
F IGURE  3  Increasing	model	complexity	demands	higher	computational	power.	Model	detail	can	be	added	by	dividing	a	well-	mixed	
population	into	separate	subpopulations,	arranged	in	a	regular	spatial	grid	or	by	means	of	complex	networks	to	represent	geographical	
distribution	of	villages,	towns	and	cities,	with	edges	corresponding	to	major	human	movement	patterns.	Depending	on	data	availability,	more	
spatial	and	demographic	detail	can	be	added	by	considering	individual	households,	places	of	work	or	schools.	However,	the	computational	
demands	increase	significantly	with	more	detailed	information	to	keep	track	of,	making	the	model	very	setting-	specific	and	impractical	for	
sensitivity	analyses	and	model	fitting	exercises
Schools
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populations	and	to	simulate	real-	world	scenarios	in	terms	of	transmis-
sion	 and	 control.	This	would	 be	 particularly	valuable	 in	 the	 context	
of	DENV	vaccination	modelling,	which	is	recent	in	the	literature	(e.g.,	
(Lourenço	 &	 Recker,	 2016;	 Flasche	 et	al.,	 2016;	 Chao	 et	al.,	 2012;	
Coudeville	&	Garnett,	2012)).	For	most	of	the	published	studies,	sim-
plifying	assumptions	are	made	on	population	heterogeneities	or	age-	
dependent	 factors,	 for	 instance.	However,	with	 the	 amelioration	 of	
computational	costs,	realistic	vaccination	campaigns	can	be	assessed,	
including	details	related	to	relative	targeting	of	rural	versus	urban	set-
tings	or	detailed	catch-	up	and	routine	strategies	dependent	on	host	
age.	In	terms	of	vector	control	programmes,	the	actual	location	of	water	
reservoirs,	the	influence	of	climate	or	host	mobility	networks	can	also	
be	 considered.	 In	 summary,	 these	 advanced	 computing	 techniques	
have	the	capacity	to	change	our	perspective	of	modelling	frameworks	
from	being	based	on	groups,	 generally	of	 individuals	 sharing	 similar	
properties	or	phenotypes,	to	a	perspective	of	host-	pathogen	systems	
focusing	on	the	role	of	single	individuals,	and	how	the	mechanics	of	
transmission	and	evolution	at	 that	 scale	 can	emerge	as	 self-	evident	
patterns	at	the	level	of	the	population.
3  | CONCLUDING REMARKS
We	have	reviewed	the	biological	and	epidemiological	background	of	
dengue,	together	with	the	major	achievements	of	computational	ap-
proaches	dedicated	to	the	pathogen.	In	addition	and	in	the	context	of	
its	increasing	success	as	a	global	threat	to	public	health,	we	have	also	
highlighted	critical	knowledge	gaps	and	research	underachievements	
that	call	 for	an	urgent	renewed	focus	and	promotion	of	such	meth-
odologies.	We	argue	that	possible	advancements,	based	on	new	pro-
cessing	strategies,	real-	time	data	sources	and	modelling	frameworks	
already	implemented	for	other	pathogens,	are	already	at	reach	of	the	
research	community.	These	new	approaches	are	expected	to	make	a	
significant	contribution	to	our	understanding	of	the	evolutionary	ecol-
ogy	and	immunology	of	the	dengue	virus	and	its	control	 in	the	near	
future.
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APPENDIX 
Data Description
Brazilian	 data	 are	 for	 suspected	 case	 counts	 from	 the	 Sistema	 de	
Informação	 de	Agravos	 de	Notificação	 (national	 notifiable	 diseases	
information	system,	SINAN)	database	(Brazil	SINAN,	http://portalsi-
nan.saude.gov.br/).	The	regions	of	north	and	south,	as	presented	 in	
Figure	1,	 present	 aggregated	 data	 (south:	 states	 of	 Paraná,	 Santa	
Catarina,	 Rio	 Grande	 do	 Sul;	 north:	 states	 of	 Rondônia,	 Acre,	
Amazonas,	Roraima,	Pará,	Amapá,	Tocantins).
Dengue	incidence	data	for	Puerto	Rico	were	provided	by	Michael	
Johansson	 from	 the	CDC	Dengue	Branch,	 comprising	 clinically	 sus-
pected	 cases	of	 dengue	 fever	 (DF)	 and	dengue	haemorrhagic	 fever	
(DHF)	in	Puerto	Rico	between	1986	and	2012.	Serotype-	specific	test-
ing	has	varied	over	 time,	 so	we	adjusted	 the	 serotype-	specific	 inci-
dence	 data	 proportionally	 to	 match	 the	 incidence	 of	 all	 suspected	
cases	by	month.	A	shorter	time	series	had	previously	been	published	
and	analysed	in	(Johansson,	Cummings,	&	Glass,	2009).
Annual	 incidence	 of	 DHF	 in	 Thailand	 1973–2009	 is	 of	 clinically	
confirmed	cases	and	was	obtained	 from	 the	annual	 epidemiological	
surveillance	reports	published	by	the	Ministry	of	Public	Health	(web-
site:	 epid.moph.go.th).	 Dengue	 serotype	 prevalence	 for	 Thailand	
1973–1999	was	based	on	children	hospitalized	at	the	Queen	Sirikit	
National	Institute	of	Child	Health	in	Bangkok,	as	previously	published	
in	(Nisalak	et	al.,	2003).
Yearly	 counts	 of	 dengue	 publications	 (1970–2016)	 were	 collected	
from	PubMed	under	two	lists	(queries).	The	first	contained	the	total	
number	of	publications	per	year	dedicated	to	dengue,	including	all	hits	
with	 reference	 to	dengue	 in	 the	 title	and	abstract	 (counts	collected	
using	the	“results	by	year”	functionality	in	PubMed).	The	second	was	
a	 subset	 of	 the	 first,	which	 included	 the	 use	 of	 dynamic	models	 in	
the	context	of	dengue	research	(manually	curated).	Queries	were	per-
formed	on	the	1st	of	February	2017.
